<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="publisher-id">Neuropsychiatric Disease and Treatment</journal-id><journal-title>Neuropsychiatric Disease and Treatment</journal-title><issn pub-type="ppub">1176-6328</issn><issn pub-type="epub">1178-2021</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18568123</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer&#x02019;s type in an elderly Arab population in Wadi Ara, Israel</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bowirrat</surname><given-names>Abdalla</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="au4">4</xref></contrib><contrib contrib-type="author"><name><surname>Waraska</surname><given-names>Kristin</given-names></name><xref ref-type="aff" rid="au5">5</xref></contrib><contrib contrib-type="author"><name><surname>Friedland</surname><given-names>Robert P</given-names></name><xref ref-type="aff" rid="au10">10</xref></contrib><contrib contrib-type="author"><name><surname>Oscar-Berman</surname><given-names>Marlene</given-names></name><xref ref-type="aff" rid="au2">2</xref><xref ref-type="aff" rid="au3">3</xref><xref ref-type="aff" rid="au6">6</xref></contrib><contrib contrib-type="author"><name><surname>Farrer</surname><given-names>Lindsay A</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au6">6</xref><xref ref-type="aff" rid="au7">7</xref><xref ref-type="aff" rid="au8">8</xref><xref ref-type="aff" rid="au9">9</xref></contrib><contrib contrib-type="author"><name><surname>Korczyn</surname><given-names>Amos</given-names></name><xref ref-type="aff" rid="au11">11</xref></contrib><contrib contrib-type="author"><name><surname>Baldwin</surname><given-names>Clinton T</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au5">5</xref><xref ref-type="aff" rid="au7">7</xref></contrib><aff id="au1"><label>1</label><institution>Genetic Program, Boston University School of Medicine</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au2"><label>2</label><institution>Department of Anatomy and Neurobiology, Boston University School of Medicine</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au3"><label>3</label><institution>Division of Psychiatry, Boston University School of Medicine</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au4"><label>4</label><institution>Hypertension Section, Boston University School of Medicine</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au5"><label>5</label><institution>Center for Human Genetics, Boston University School of Medicine</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au6"><label>6</label><institution>Department of Neurology, Boston University School of Medicine</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au7"><label>7</label><institution>Department of Genetics and Genomics, Boston University School of Medicine</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au8"><label>8</label><institution>Department of Epidemiology, Boston University School of Public Health</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au9"><label>9</label><institution>Department of Biostatistics, Boston University School of Public Health</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au10"><label>10</label><institution>Department of Neurology, Case Western Reserve University</institution><addr-line>Cleveland, OH, USA</addr-line></aff><aff id="au11"><label>11</label><institution>Department of Neurology, Tel Aviv University</institution><addr-line>Tel Aviv, Israel</addr-line></aff></contrib-group><author-notes><corresp>Correspondence: Abdalla Bowirrat Department of Anatomy and Neurobiology, Laboratory of Neuropsychology, Boston University School of Medicine, 715 Albany Street, L-815 Boston, MA 02118, USA Tel +1 617 638 4807 Fax +1 617 638 4806 Email <email>bowirrat@bu.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2005</year></pub-date><volume>1</volume><issue>1</issue><fpage>73</fpage><lpage>76</lpage><copyright-statement>&#x000a9; 2005 Dove Medical Press Limited. All rights reserved</copyright-statement><copyright-year>2005</copyright-year><abstract><p>The angiotensin-converting enzyme (ACE), a protease involved in blood pressure regulation, has been implicated as an important candidate gene for Alzheimer&#x02019;s disease (AD). This study investigated whether the ACE gene insertion&#x02013;deletion (ID) polymorphism is associated with risk of developing dementia of Alzheimer&#x02019;s type (DAT) in an Arab&#x02013;Israeli community, a unique genetic isolate where there is a high prevalence of DAT. In contrast to several other studies, we found no evidence of an association between this polymorphism and either DAT or age-related cognitive decline (ARCD).</p></abstract><kwd-group><kwd>angiotensin-converting enzyme</kwd><kwd>dementia of the Alzheimer&#x02019;s type</kwd><kwd>age-related cognitive decline</kwd><kwd>insertion&#x02013;deletion polymorphism</kwd><kwd>Arab population</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Alzheimer&#x02019;s disease (AD) is a catastrophic affliction of the middle and later years of life. Clinically, it is marked by an irreversible decline in mental abilities, including progressive loss of memory, confusion, and dementia, and culminates in childlike helplessness. In the United States, the incidence of AD is exponentially increasing and is projected to affect 8.64 million people by the year 2047 (<xref ref-type="bibr" rid="b18">Grossberg 2003</xref>). Median survival times range from 8.3 years for persons diagnosed at age 65, to 3.4 years for persons diagnosed at age 90 (<xref ref-type="bibr" rid="b10">Brookmeyer et al 2002</xref>).</p><p>Angiotensin-converting enzyme (ACE) catalyzes the conversion of angiotensin I into a physiologically active peptide, angiotensin II. This reaction is an important process in blood pressure regulation. In addition to this well known physiologic role, ACE is able to cleave other proteins, including bradykinin and substance P, and has been shown to inhibit and cleave amyloid &#x003b2;-peptide (A&#x003b2;) aggregation and amyloid plaque formation in vitro (<xref ref-type="bibr" rid="b21">Hu et al 2001</xref>). ACE may contribute to the pathogenesis of AD.</p><p>To test the hypothesis of association between ACE and DAT, we evaluated an insertion&#x02013;deletion (ID) polymorphism in the ACE gene as a potential risk factor for dementia of the Alzheimer&#x02019;s type (DAT) in an Arab community in Wadi Ara, Israel. The population comprised 853 persons over the age of 65 (<xref ref-type="bibr" rid="b9">Bowirrat et al 2001</xref>; <xref ref-type="bibr" rid="b7">Bowirrat, Friedland, Farrer, et al 2002</xref>). Family studies revealed that more than one-third of DAT cases are members of one extended family. We hypothesized that DAT in Wadi Ara may be due to a founder effect enhanced by consanguinity; thus, a specific disease susceptibility allele may be overrepresented in cognitively impaired subjects compared with cognitively healthy residents. Our results suggest that the ACE-ID polymorphism is not associated with either DAT or age-related cognitive decline (ARCD) in this Arab community.</p></sec><sec sec-type="methods"><title>Methods and results</title><p>Subjects were sourced from a prevalence study of dementia conducted in Wadi Ara, a geographically defined area in northern Israel comprising three Arab villages (<xref ref-type="bibr" rid="b9">Bowirrat et al 2001</xref>). Among the original list of 853 residents aged 65 years and older (prevalence date, October, 1995), 823 (363 males and 460 females) were available and consented to participate in the study. Only 30 patients (23 females and 7 males) were excluded from the original list of the study (853) because they did not fulfill the diagnostic criteria for DAT and ARCD (they were classified with other medical conditions). Among the excluded females (n = 23), 19 suffered from vascular dementia (VaD), 1 patient had Parkinson&#x02019;s disease (PD), and 3 had pseudodementia. Among the excluded males (n = 7), 5 suffered from PD and 2 patients were diagnosed with VaD. The sex-specific prevalence of DAT among males and females was 53/363 = 14.6% and 115/460 = 25%, respectively; and the sex-specific prevalence of ARCD among males and females was 118/354 = 33.3% and 236/354 = 66.6%, respectively. These subjects were interviewed and examined by an Arabic-speaking neurologist (AB). Each subject underwent a battery of standard cognitive tests modified to fit the cultural and linguistic characteristics of this community (<xref ref-type="bibr" rid="b9">Bowirrat et al 2001</xref>). The diagnosis of DAT and ARCD was determined using DSM-IV criteria (<xref ref-type="bibr" rid="b4">APA 1994</xref>). Those with a medical history and laboratory or cognitive test results that suggested the presence of other illnesses, such as vascular dementia, Parkinson&#x02019;s disease, normal-pressure hydrocephalus, or pseudodementia (depression), were excluded. Peripheral blood samples were obtained from the 650 subjects for DNA analysis.</p><p>To genotype the ACE-ID polymorphism, 2 polymerase chain reactions (PCRs) were performed. In the first reaction, primers that flank the ID polymorphism were used to amplify DNA from each subject (5&#x02032;-CTGGAGACC ACTCCCATCCTTTCT and 5&#x02032;-TTGATGAGTTCCAC GTATTTCG). The resulting PCR product was analyzed on a 2% agarose gel for the presence or absence of the 287-bp insertion&#x02013;deletion polymorphism. Because this reaction frequently fails to detect the insertion variant, a second PCR reaction was performed that specifically amplifies the allele containing the insertion (primers 5&#x02032;-CTGGGATTA CAGGCGTGATACA and 5&#x02032;-TTGATGAGTTCCAC GTATTTCG). The data from both reactions were used to establish the ACE-ID genotype. For statistical analysis, the Hardy-Weinberg equilibrium (HWE) was assessed for each group (DAT, ARCD, normal). Allele and genotype frequencies were compared among groups by a &#x003c7;<sup>2</sup> test.</p><p>The results of the ACE (ID) genotyping (<xref ref-type="table" rid="tbl1">Table 1</xref>) showed that the frequency of the I allele was 32% in cognitively normal control, 26% in DAT cases (p = 0.2223), and 32% in ARCD cases (p = 0.9559). The genotype frequency distribution in the control groups were also similar to those for DAT cases (p = 0.3731) and ARCD cases (p = 0.9973). Therefore, our results suggest that the ID polymorphism within ACE is not associated with DAT or ARCD in this Arab community (<xref ref-type="table" rid="tbl1">Table 1</xref>).</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Genotypic and allelic frequencies among ARCD, DAT, and cognitively normal control</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">ACE-ID</th><th align="left" rowspan="1" colspan="1">Normal</th><th align="left" rowspan="1" colspan="1">ARCD</th><th align="right" rowspan="1" colspan="1">DAT</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">8 (7.14)</td><td align="left" rowspan="1" colspan="1">3 (6.82)</td><td align="right" rowspan="1" colspan="1">5 (5.88)</td></tr><tr><td align="left" rowspan="1" colspan="1">DI</td><td align="left" rowspan="1" colspan="1">56 (50)</td><td align="left" rowspan="1" colspan="1">22 (50)</td><td align="right" rowspan="1" colspan="1">35 (41.18)</td></tr><tr><td align="left" rowspan="1" colspan="1">DD</td><td align="left" rowspan="1" colspan="1">48 (42.86)</td><td align="left" rowspan="1" colspan="1">19 (43.18)</td><td align="right" rowspan="1" colspan="1">45 (52.94)</td></tr><tr><td align="left" rowspan="1" colspan="1">f(I)</td><td align="left" rowspan="1" colspan="1">72 (32.14)</td><td align="left" rowspan="1" colspan="1">28 (31.82)</td><td align="right" rowspan="1" colspan="1">45 (26.47)</td></tr></tbody><tbody><tr><td colspan="4" align="left" rowspan="1"><bold>Table 1a</bold> Genotypic p-value</td></tr><tr><td colspan="4" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Group</td><td colspan="2" align="left" rowspan="1">ARCD</td><td align="right" rowspan="1" colspan="1">Normal</td></tr><tr><td colspan="4" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">DAT</td><td colspan="2" align="left" rowspan="1">0.5745</td><td align="right" rowspan="1" colspan="1">0.3731</td></tr><tr><td align="left" rowspan="1" colspan="1">ARCD</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td align="right" rowspan="1" colspan="1">0.9973</td></tr></tbody><tbody><tr><td colspan="4" align="left" rowspan="1"><bold>Table 1b</bold> Allelic p-value</td></tr><tr><td colspan="4" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Group</td><td colspan="2" align="left" rowspan="1">ARCD</td><td align="right" rowspan="1" colspan="1">Normal</td></tr><tr><td colspan="4" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">DAT</td><td colspan="2" align="left" rowspan="1">0.3660</td><td align="right" rowspan="1" colspan="1">0.2223</td></tr><tr><td align="left" rowspan="1" colspan="1">ARCD</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td align="right" rowspan="1" colspan="1">0.9559</td></tr></tbody></table><table-wrap-foot><fn id="tf1-1"><p><bold>Abbreviations:</bold> ACE, angiotensin-converting enzyme; I, insertion allele; D, deletion allele; ARCD, age-related cognitive decline; DAT, dementia of Alzheimer&#x02019;s type; f(I), frequency of the insertion allele.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>AD is the most overdiagnosed and misdiagnosed disorder of mental functioning in older adults. Part of the problem, is that many other disorders show symptoms that resemble those of AD. The crucial difference, however, is that many of these disorders &#x02013; unlike AD &#x02013; may be stopped, reversed, or cured. Based on these findings, clinical diagnosis of AD has been referred to as &#x0201c;a diagnosis by exclusion&#x0201d;, and one that can only be made in the face of clinical deterioration over time. There is no specific clinical test or finding that is unique to AD. Hence, all disorders that can bring on similar symptoms must be systematically excluded. The &#x0201c;classical&#x0201d; senile plaques and the neurofibrillary tangles seen in an AD brain at autopsy typically are the only definitive diagnosis of the disease.</p><p>We did not observe an association between the ACE-ID polymorphism and DAT or ARCD in the elderly Arab population of Wadi Ara. Notably, inherited susceptibility for DAT in Wadi Ara is also not accounted for by the ApoE &#x003b5;4 allele. Indeed, the frequency of ApoE &#x003b5;4 among DAT, ARCD, and control was 0.027, 0.033, and 0.029, respectively (<xref ref-type="bibr" rid="b6">Bowirrat et al 2000</xref>).</p><p>Nonetheless, the relationship between ACE and AD is controversial. Several studies have implicated the ID polymorphism and risk of AD (<xref ref-type="bibr" rid="b29">Narain et al 2000</xref>; <xref ref-type="bibr" rid="b12">Cheng et al 2002</xref>; <xref ref-type="bibr" rid="b24">Kehoe et al 2003</xref>; <xref ref-type="bibr" rid="b15">Elkins et al 2004</xref>; <xref ref-type="bibr" rid="b37">Tian et al 2004</xref>), while other studies failed to find an association (<xref ref-type="bibr" rid="b28">Myllykangas et al 2000</xref>; <xref ref-type="bibr" rid="b36">Taylor et al 2001</xref>; <xref ref-type="bibr" rid="b11">Buss et al 2002</xref>; <xref ref-type="bibr" rid="b26">Lendon et al 2002</xref>; <xref ref-type="bibr" rid="b27">Monastero et al 2002</xref>; <xref ref-type="bibr" rid="b19">Harrap et al 2003</xref>; <xref ref-type="bibr" rid="b31">Panza et al 2003</xref>). Moreover, the pattern of association has been confusing, with some studies showing an association with the I allele (<xref ref-type="bibr" rid="b2">Alvarez et al 1999</xref>; <xref ref-type="bibr" rid="b39">Yang et al 2000</xref>; <xref ref-type="bibr" rid="b21">Hu et al 2001</xref>), while others with the D allele (<xref ref-type="bibr" rid="b3">Amouyel et al 1996</xref>; <xref ref-type="bibr" rid="b30">Palumbo et al 1999</xref>; <xref ref-type="bibr" rid="b13">Crawford et al 2000</xref>; <xref ref-type="bibr" rid="b16">Farrer et al 2000</xref>; <xref ref-type="bibr" rid="b33">Richard et al 2001</xref>).</p><p>The reasons for the disparity in results across studies may be due to differences in ethnic background, different environmental factors, or subject misclassification. To date, few studies have examined the frequency of the ACE genotypes in autopsy-confirmed cases of AD, or investigated the potential effect of these ACE genotypes on the pathology of the disorder. In one autopsy series, the ACE genotype was not associated with the amount of A &#x003b2;<sub>40</sub>, A&#x003b2;<sub>42</sub>, or pathological tau protein deposited within the frontal cortex, or in the extent of amyloid angiopathy in the brain, whether ApoE &#x003b5;4 allele was present or not (<xref ref-type="bibr" rid="b26">Lendon et al 2002</xref>). The only other autopsy-based study of ACE (based on an elderly Finnish population) also failed to detect an association with ACE (<xref ref-type="bibr" rid="b28">Myllykangas et al 2000</xref>). In the Arab community, autopsy is prohibited for religious and traditional reasons. Other limitations of our study are the absence of biomarkers and complete biochemical examinations, and the low number of neuroimaging performed. These helpful clinical techniques are necessary to improve our clinical diagnosis of DAT and are required to differentiate it from similar clinical manifestation that mimic the presentation of dementia.</p><p>A possible biological explanation for an association between ACE and AD is still unclear. The insertion allele appears to reduce ACE expression, and DD homozygotes and ID heterozygotes have more circulating ACE than II homozygotes: 65%, and 31%, respectively (<xref ref-type="bibr" rid="b34">Rieder et al 1999</xref>). This increased activity of the D allele may alter A&#x003b2; deposition by a direct proteolytic mechanism (<xref ref-type="bibr" rid="b24">Kehoe et al 2003</xref>). Alternatively, ACE may have an indirect role in the progression of AD. The ID polymorphism has also been implicated in various conditions including hypertension (<xref ref-type="bibr" rid="b40">Zaman et al 2002</xref>; <xref ref-type="bibr" rid="b20">Hopkins and Hunt 2003</xref>), coronary heart disease (<xref ref-type="bibr" rid="b5">Arbustini et al 1995</xref>; <xref ref-type="bibr" rid="b23">Kauma et al 1996</xref>), cardiomyopathy (<xref ref-type="bibr" rid="b32">Pfohl et al 1998</xref>), stroke (<xref ref-type="bibr" rid="b14">de la Torre et al 2002</xref>), and juvenile rheumatoid arthritis (<xref ref-type="bibr" rid="b1">Alsaeid et al 2003</xref>). Other studies don&#x02019;t confirm these associations (see <xref ref-type="bibr" rid="b38">Ueda et al 1995</xref>; <xref ref-type="bibr" rid="b22">Hung et al 1999</xref>; <xref ref-type="bibr" rid="b19">Harrap et al 2003</xref>).</p><p>Several studies suggest that there may be a relationship between cardiovascular lesions and the severity and progression of AD (<xref ref-type="bibr" rid="b35">Snowdon et al 1997</xref>; <xref ref-type="bibr" rid="b41">Zuliani et al 2001</xref>; <xref ref-type="bibr" rid="b7">Bowirrat, Friedland, Korczyn 2002</xref>; <xref ref-type="bibr" rid="b14">de la Torre 2002</xref>; <xref ref-type="bibr" rid="b25">Korczyn 2002</xref>). In summary, in the present study, we found a lack of association between ACE and DAT. Our previous studies have not determined any gene that may explain the high prevalence of DAT in this community, but we have found high prevalence of vascular dementia (VaD) following stroke. Indeed, the prevalence of VaD constitutes 5.9% of the total elderly Arab population in Wadi Ara and about 22% of the total dementia population (<xref ref-type="bibr" rid="b7">Bowirrat, Friedland, Korczyn 2002</xref>). This prevalence of VaD (22%) is extremely high compared with VaD patients who accounted for only 6% of all dementia patients identified by <xref ref-type="bibr" rid="b17">Fillit and Hill (2002)</xref>. Given the role of the ACE gene in vascular disease as well as in AD, the ability to detect association with AD may be complex. On the other hand, and in light of the high frequency of VaD in this population, a new study to evaluate the role of ACE in VaD is essential.</p></sec></body><back><ack><p>This work was supported in part by grants from the National Institute of Health (U01-AG17173), the Institute for the Study of Aging, NIAAA (R37-AA07112), and the US Department of Veterans Affairs.</p></ack><ref-list><title>References</title><ref id="b1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alsaeid</surname><given-names>K</given-names></name><name><surname>Haider</surname><given-names>MZ</given-names></name><name><surname>Ayoub</surname><given-names>EM</given-names></name></person-group><article-title>Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis</article-title><source>J Rheumatol</source><year>2003</year><volume>30</volume><fpage>2705</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14719217</pub-id></citation></ref><ref id="b2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>R</given-names></name><name><surname>Alvarez</surname><given-names>V</given-names></name><name><surname>Lahoz</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer&#x02019;s disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1999</year><volume>67</volume><fpage>733</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10567488</pub-id></citation></ref><ref id="b3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Richard</surname><given-names>F</given-names></name><name><surname>Cottel</surname><given-names>D</given-names></name><etal/></person-group><article-title>The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment</article-title><source>Neurosci Lett</source><year>1996</year><volume>217</volume><fpage>203</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8916108</pub-id></citation></ref><ref id="b4"><citation citation-type="book"><collab>[APA] American Psychiatric Association</collab><source>Diagnostic and statistical manual of mental disorders &#x02013; Fourth edition (DSM-IV)</source><year>1994</year><publisher-loc>Washington</publisher-loc><publisher-name>APA</publisher-name></citation></ref><ref id="b5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arbustini</surname><given-names>E</given-names></name><name><surname>Grasso</surname><given-names>M</given-names></name><name><surname>Fasani</surname><given-names>R</given-names></name><etal/></person-group><article-title>Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction</article-title><source>Br Heart J</source><year>1995</year><volume>74</volume><fpage>584</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">8541160</pub-id></citation></ref><ref id="b6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowirrat</surname><given-names>A</given-names></name><name><surname>Friedland</surname><given-names>RP</given-names></name><name><surname>Chapman</surname><given-names>J</given-names></name><etal/></person-group><article-title>The very high prevalence of AD in an Arab population is not explained by APOE &#x003b5;4 allele frequency</article-title><source>Neurology</source><year>2000</year><volume>55</volume><fpage>731</fpage><pub-id pub-id-type="pmid">10980749</pub-id></citation></ref><ref id="b7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowirrat</surname><given-names>A</given-names></name><name><surname>Friedland</surname><given-names>RP</given-names></name><name><surname>Farrer</surname><given-names>L</given-names></name><etal/></person-group><article-title>Genetic and environmental risk factors for Alzheimer&#x02019;s disease in Israeli Arabs</article-title><source>J Mol Neurosci</source><year>2002</year><volume>19</volume><fpage>239</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12212789</pub-id></citation></ref><ref id="b8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowirrat</surname><given-names>A</given-names></name><name><surname>Friedland</surname><given-names>RP</given-names></name><name><surname>Korczyn</surname><given-names>AD</given-names></name></person-group><article-title>Vascular dementia among elderly Arabs in Wadi Ara</article-title><source>J Neurol Sci</source><year>2002</year><fpage>203</fpage><lpage>204</lpage><fpage>73</fpage><lpage>6</lpage></citation></ref><ref id="b9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowirrat</surname><given-names>A</given-names></name><name><surname>Treves</surname><given-names>TA</given-names></name><name><surname>Friedland</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Prevalence of Alzheimer&#x02019;s type dementia in an elderly Arab population</article-title><source>Eur J Neurol</source><year>2001</year><volume>8</volume><fpage>119</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">11284991</pub-id></citation></ref><ref id="b10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brookmeyer</surname><given-names>R</given-names></name><name><surname>Corrada</surname><given-names>MM</given-names></name><name><surname>Kawas</surname><given-names>C</given-names></name></person-group><article-title>Survival following a diagnosis of Alzheimer&#x02019;s disease</article-title><source>Arch Neurol</source><year>2002</year><volume>59</volume><fpage>1764</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12433264</pub-id></citation></ref><ref id="b11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buss</surname><given-names>S</given-names></name><name><surname>Muller-Thomsen</surname><given-names>T</given-names></name><name><surname>Hoch</surname><given-names>C</given-names></name><etal/></person-group><article-title>No association between DCP1 genotype and late-onset Alzheimer&#x02019;s disease</article-title><source>Am J Med Gen</source><year>2002</year><volume>114</volume><fpage>440</fpage><lpage>5</lpage></citation></ref><ref id="b12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C-Y</given-names></name><name><surname>Hong</surname><given-names>C-J</given-names></name><name><surname>Lui</surname><given-names>H-C</given-names></name><etal/></person-group><article-title>Study of the association between Alzheimer&#x02019;s disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes</article-title><source>Eur Neurol</source><year>2002</year><volume>47</volume><fpage>26</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11803189</pub-id></citation></ref><ref id="b13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>F</given-names></name><name><surname>Abdullah</surname><given-names>L</given-names></name><name><surname>Schinka</surname><given-names>J</given-names></name><etal/></person-group><article-title>Gender-specific association of the angiotensin converting enzyme gene with Alzheimer&#x02019;s disease</article-title><source>Neurosci Lett</source><year>2000</year><volume>280</volume><fpage>215</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">10675799</pub-id></citation></ref><ref id="b14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de la Torre</surname><given-names>JC</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease as a vascular disorder: nosological evidence</article-title><source>Stroke</source><year>2002</year><volume>33</volume><fpage>1152</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">11935076</pub-id></citation></ref><ref id="b15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elkins</surname><given-names>JS</given-names></name><name><surname>Douglas</surname><given-names>VC</given-names></name><name><surname>Johnston</surname><given-names>SC</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease risk and genetic variation in ACE</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>363</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14872014</pub-id></citation></ref><ref id="b16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farrer</surname><given-names>LA</given-names></name><name><surname>Sherbatich</surname><given-names>T</given-names></name><name><surname>Keryanov</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Association between angiotensin-converting enzyme and Alzheimer&#x02019;s disease</article-title><source>Arch Neurol</source><year>2000</year><volume>57</volume><fpage>210</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">10681079</pub-id></citation></ref><ref id="b17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fillit</surname><given-names>H</given-names></name><name><surname>Hill</surname><given-names>J</given-names></name></person-group><article-title>The costs of vascular dementia: a comparison with Alzheimer&#x02019;s disease</article-title><source>J Neurol Sci</source><year>2002</year><volume>15</volume><fpage>203</fpage><lpage>204</lpage><fpage>35</fpage><lpage>9</lpage></citation></ref><ref id="b18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grossberg</surname><given-names>GT</given-names></name></person-group><article-title>Diagnosis and treatment of Alzheimer&#x02019;s disease</article-title><source>J Clin Psychiatry</source><year>2003</year><volume>64</volume><issue>Suppl 9</issue><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12934967</pub-id></citation></ref><ref id="b19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrap</surname><given-names>SB</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><name><surname>Cambien</surname><given-names>F</given-names></name><etal/></person-group><article-title>The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition</article-title><source>Hypertension</source><year>2003</year><volume>42</volume><fpage>297</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">12925557</pub-id></citation></ref><ref id="b20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>PN</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name></person-group><article-title>Genetics of hypertension</article-title><source>Genet Med</source><year>2003</year><volume>5</volume><fpage>413</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">14614392</pub-id></citation></ref><ref id="b21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Igarashi</surname><given-names>A</given-names></name><name><surname>Kamata</surname><given-names>M</given-names></name><etal/></person-group><article-title>Angiotensin-converting enzyme degrades Alzheimer amyloid &#x003b2;-peptide (A&#x003b2;); retards A&#x003b2; aggregation, deposition, fibril formation; and inhibits cytotoxicity</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>47863</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11604391</pub-id></citation></ref><ref id="b22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>J</given-names></name><name><surname>McQuillan</surname><given-names>BM</given-names></name><name><surname>Nidorf</surname><given-names>M</given-names></name><etal/></person-group><article-title>Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1999</year><volume>19</volume><fpage>1969</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">10446079</pub-id></citation></ref><ref id="b23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kauma</surname><given-names>H</given-names></name><name><surname>Paivansalo</surname><given-names>M</given-names></name><name><surname>Savolainen</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis</article-title><source>J Hypertens</source><year>1996</year><volume>14</volume><fpage>1183</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8906516</pub-id></citation></ref><ref id="b24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kehoe</surname><given-names>PG</given-names></name><name><surname>Katzov</surname><given-names>H</given-names></name><name><surname>Feuk</surname><given-names>L</given-names></name><etal/></person-group><article-title>Haplotypes extending across ACE are associated with Alzheimer&#x02019;s disease</article-title><source>Hum Mol Genet</source><year>2003</year><volume>12</volume><fpage>859</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">12668609</pub-id></citation></ref><ref id="b25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korczyn</surname><given-names>AD</given-names></name></person-group><article-title>Mixed dementia &#x02013; the most common cause of dementia</article-title><source>Ann N Y Acad Sci</source><year>2002</year><volume>977</volume><fpage>129</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12480742</pub-id></citation></ref><ref id="b26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lendon</surname><given-names>CL</given-names></name><name><surname>Thaker</surname><given-names>U</given-names></name><name><surname>Harris</surname><given-names>JM</given-names></name><etal/></person-group><article-title>The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer&#x02019;s disease</article-title><source>Neurosci Lett</source><year>2002</year><volume>328</volume><fpage>314</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">12147333</pub-id></citation></ref><ref id="b27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monastero</surname><given-names>R</given-names></name><name><surname>Caldarella</surname><given-names>R</given-names></name><name><surname>Mannino</surname><given-names>M</given-names></name><etal/></person-group><article-title>Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer&#x02019;s disease</article-title><source>Neurosci Lett</source><year>2002</year><volume>335</volume><fpage>147</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12459519</pub-id></citation></ref><ref id="b28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myllykangas</surname><given-names>L</given-names></name><name><surname>Polvikoski</surname><given-names>T</given-names></name><name><surname>Sulkava</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cardiovascular risk factors and Alzheimer&#x02019;s disease: a genetic association study in a population aged 85 or over</article-title><source>Neurosci Lett</source><year>2000</year><volume>292</volume><fpage>195</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11018310</pub-id></citation></ref><ref id="b29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narain</surname><given-names>Y</given-names></name><name><surname>Yip</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>T</given-names></name><etal/></person-group><article-title>The ACE gene and Alzheimer&#x02019;s disease susceptibility</article-title><source>J Med Genet</source><year>2000</year><volume>37</volume><fpage>695</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10978362</pub-id></citation></ref><ref id="b30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palumbo</surname><given-names>B</given-names></name><name><surname>Cardini</surname><given-names>D</given-names></name><name><surname>Nocentini</surname><given-names>G</given-names></name><etal/></person-group><article-title>Angiotensin converting enzyme deletion allele in different kinds of dementia disorders</article-title><source>Neurosci Lett</source><year>1999</year><volume>267</volume><fpage>97</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">10400221</pub-id></citation></ref><ref id="b31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panza</surname><given-names>F</given-names></name><name><surname>Solfrizzi</surname><given-names>V</given-names></name><name><surname>D&#x02019;Introno</surname><given-names>A</given-names></name><etal/></person-group><article-title>Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer&#x02019;s disease risk</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2003</year><volume>74</volume><fpage>1157</fpage><lpage>61</lpage></citation></ref><ref id="b32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfohl</surname><given-names>M</given-names></name><name><surname>Fetter</surname><given-names>M</given-names></name><name><surname>Kock</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association between angiotensin I-converting enzyme genotypes, extracranial artery stenosis, and stroke</article-title><source>Atherosclerosis</source><year>1998</year><volume>140</volume><fpage>161</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9733227</pub-id></citation></ref><ref id="b33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>F</given-names></name><name><surname>Fromentin-David</surname><given-names>I</given-names></name><name><surname>Ricolfi</surname><given-names>F</given-names></name><etal/></person-group><article-title>The angiotensin I converting enzyme gene as a susceptibility factor for dementia</article-title><source>Neurology</source><year>2001</year><volume>56</volume><fpage>1593</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11402126</pub-id></citation></ref><ref id="b34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rieder</surname><given-names>MJ</given-names></name><name><surname>Taylor</surname><given-names>SL</given-names></name><name><surname>Clark</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Sequence variation in the human angiotensin converting enzyme</article-title><source>Nat Genet</source><year>1999</year><volume>22</volume><fpage>59</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">10319862</pub-id></citation></ref><ref id="b35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Snowdon</surname><given-names>DA</given-names></name><name><surname>Greiner</surname><given-names>LH</given-names></name><name><surname>Mortimer</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Brain infarction and the clinical expression of Alzheimer&#x02019;s disease. The Nun Study</article-title><source>JAMA</source><year>1997</year><volume>277</volume><fpage>813</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">9052711</pub-id></citation></ref><ref id="b36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Ezquerra</surname><given-names>M</given-names></name><name><surname>Bargri</surname><given-names>G</given-names></name><etal/></person-group><article-title>Alzheimer&#x02019;s disease not associated with polymorphism in the angiotensinogen and rennin genes</article-title><source>Am J Med Gen</source><year>2001</year><volume>105</volume><fpage>761</fpage><lpage>4</lpage></citation></ref><ref id="b37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Bailey</surname><given-names>K</given-names></name><etal/></person-group><article-title>A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer&#x02019;s disease</article-title><source>Neurosci Lett</source><year>2004</year><volume>354</volume><fpage>103</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14698449</pub-id></citation></ref><ref id="b38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>S</given-names></name><name><surname>Weir</surname><given-names>CJ</given-names></name><name><surname>Inglis</surname><given-names>GC</given-names></name><etal/></person-group><article-title>Lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and stroke</article-title><source>J Hypertens</source><year>1995</year><volume>13</volume><fpage>1597</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">8903617</pub-id></citation></ref><ref id="b39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>JD</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>ZX</given-names></name><etal/></person-group><article-title>Association between angiotensin-converting enzyme gene and late onset Alzheimer&#x02019;s disease in Han Chinese</article-title><source>Neurosci Lett</source><year>2000</year><volume>295</volume><fpage>41</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11078932</pub-id></citation></ref><ref id="b40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>MA</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name><name><surname>Calhoun</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Drugs targeting the rennin-angiotensin-aldesterone system</article-title><source>Nat Rev Drug Discov</source><year>2002</year><volume>1</volume><fpage>621</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">12402502</pub-id></citation></ref><ref id="b41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuliani</surname><given-names>G</given-names></name><name><surname>Ble</surname><given-names>A</given-names></name><name><surname>Zanca</surname><given-names>R</given-names></name><etal/></person-group><article-title>Genetic polymorphisms in older subjects with vascular or Alzheimer&#x02019;s dementia</article-title><source>Acta Neurol Scand</source><year>2001</year><volume>103</volume><fpage>304</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11328206</pub-id></citation></ref></ref-list></back></article> 